Aprea Therapeutics logo
Aprea Therapeutics
APRE | NASDAQ
Chart Builder DCF Calculator
$0.45
-$0.05 (-10.18%)
At close: Nov 10, 2026, 4:00 PM ET

Aprea Therapeutics Cash Flow Statement

Cash flow statement explained
TTM
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-14.14M -12.31M -11.95M -12.6M -13.04M -13.85M -14.08M -12.96M -13.51M -12.93M -12.72M -14.29M -13.29M -14.11M -109.11M -112.66M -117.98M -123.4M -35.4M -37.13M -44.76M -47.63M -53.75M
22.51K 22.03K 21.71K 21.72K 21.71K 21.71K 21.59K 22.32K 21.88K 17.88K 12.8K 7.05K -319 59.62K 123.09K 186.45K 254.82K 262.9K 259.44K 271.68K 262.58K 249.82K 237.84K
411.98K 427.04K 460.58K 478.14K 495.15K 530.48K 522.24K 489.44K 446.27K 373.21K 514.05K 444.46K 418.95K 381.16K 14.91M 16.98M 19.02M 21.01M 8.08M 7.81M 7.15M 5.12M 4.51M
337.89K -89.83K -80.08K -282.39K -455.74K 251.88K 267.73K -741.19K -1.1M -887.52K -1.41M 791.25K 686.08K -253.35K 272.25K -900.07K -3.26M -4.57M -3.2M -5.6M -2.48M -686.41K -1.01M
34.24K 42.78K 74.86K 134.37K 47.43K 77.24K 53.61K -54.37K 63.43K 30.82K -31.05K 38.93K -6.09K -33.32K 72.39M 72.24M 72.14M 72.18M 68.37K -317.4K 926.65K 268.6K 1.91M
– – – – – – – – – – – – – – – – – – – – – – –
951.87K -352.6K -622.32K -929.1K -969.61K 479.54K 231.85K -1.06M -809.88K -1.05M -913.26K 1.62M 414.64K -3.11M -817.97K -1.76M -4.6M -2.87M -4.67M -8.33M -4.29M -3.64M -424.2K
-12.72M -12.17M -12.02M -12.89M -13.44M -12.74M -13.25M -13.56M -13.79M -13.56M -13.13M -12.18M -12.46M -16.81M -22.49M -25.01M -31.17M -32.81M -31.66M -37.69M -40.71M -45.63M -47.52M
-15.4K -15.4K – – – – -7.5K -15.48K -22.63K -108.57K -101.07K -93.09K -85.94K – – – – – – – -16.29K -16.13K -14.11K
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
-348 -348 – – – – – – – – – – – – – – – – – – – – –
-15.75K -15.75K – – – – -7.5K -15.48K -22.63K -108.57K -101.07K -93.09K -85.94K – – – – – – – -16.29K -16.14K -14.11K
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
-2.94M -3.3M -878.65K -407.37K -42.08K -25.8K -31.95K -1.32M -1.31M -1.31M -1.29M -648.93K -648.93K -648.93K -648.93K – 1.66M 1.75M 1.75M 1.75M 86.97K – 121.43K
36.87M 36.89M 39.21M 4.64M 933.07K 573.98K 168.04K 14.82M 14.69M 14.69M 14.71M 5.14M 5.24M 5.82M 5.82M 682.97K 2.24M 1.75M 1.75M 1.75M 86.97K 9.14K 130.57K
24.13M 24.7M 27.19M -8.25M -12.53M -12.16M -13.09M 1.24M 897.2K 1.01M 1.42M -7.14M -7.72M -11.34M -16.66M -24.29M -28.32M -30.74M -29.96M -35.94M -39.72M -43.06M -44.9M
-12.74M -12.18M -12.02M -12.89M -13.44M -12.74M -13.26M -13.57M -13.81M -13.67M -13.24M -12.27M -12.54M -16.81M -22.49M -25.01M -31.17M -32.81M -31.66M -37.69M -40.72M -45.65M -47.53M
-13.15M -12.61M -12.48M -13.37M -13.94M -13.27M -13.78M -14.06M -14.25M -14.04M -13.75M -12.72M -12.96M -17.19M -37.41M -41.99M -50.18M -53.82M -39.73M -45.5M -47.88M -50.76M -52.04M
-5.75K -5.75K – – – – – – – – – – – – – – – – – – -16.29K -16.45K -18.47K
-9.65K -9.65K – – – – -7.5K -15.48K -22.63K -108.57K -101.07K -93.09K -85.94K – – – – – – – – 310.43 4.35K
-12.73M -12.17M -12.02M -12.89M -13.44M -12.74M -13.25M -13.56M -13.79M -13.56M -13.13M -12.18M -12.46M -16.81M -22.49M -25.01M -31.17M -32.81M -31.66M -37.69M -40.72M -45.65M -47.54M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.